All medicines centrally authorised in the EU (EMA)
pertuzumab
ustekinumab
tislelizumab
polatuzumab vedotin
resmetirom
Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B
setmelanotide
L03AB07
Pomalidomide
carglumic acid
riociguat
inebilizumab
Crovalimab
yttrium (90Y) chloride
macitentan;tadalafil
trametinib
sepiapterin
denosumab
M05BX04
Page 22 of 134 • 20 of 2,678 Medicines